Participants 64 131 5
in patients with type 2 diabetes and high-normal body lead burdens.
Participants 161 223 3
in type 2 diabetic patients with high-normal body lead burdens
Participants 575 695 6
University medical center; 50 patients (serum creatinine, 1.5-3.9 mg/dL) with high-normal body lead burden (â‰¥80-<600 Î
Participants 1396 1433 4
for Chinese patients with type 2 diab
Participants 1946 2014 4
 group. 17 (68%) control-group patients and 9 (36%) treatment-group 
Participants 2205 2264 4
athy in type 2 diabetic patients with high-normal body lead
